Description: Today's best AIs often match human experts on routine tasks - but AI automation success requires skilled implementation. Nathan will present a field-tested, three-step method for automating cognitive work: (1) understanding what AI can do & choosing the right tasks, (2) documenting processes in the form of ""gold standard examples"", and (3) systematically optimizing AI performance – all using concrete examples from actuarial practice. Master this approach and amplify your own expertise by automating repetitive work with AI. Nathan Labenz, founder and former CEO of Waymark, is a technology entrepreneur and artificial intelligence analyst. With a background in science and an eye for innovation, Nathan led Waymark from its inception to its status as a trailblazer in generative AI-powered video creation. Currently, he hosts 'The Cognitive Revolution' podcast, where he explores the transformative impact of artificial intelligence on work, life, society, and culture. Through his conversations with notable builders, researchers, and investors, Nathan helps business, policy, and academic leaders stay up to date with AI developments and implications.

Description: Building new models or migrating from one system to another is hard! During this session, you will hear from your colleagues who have gone through such projects. You will gain a better sense of what to expect, what to avoid, and what to prioritize for such projects. The discussion will be system agnostic. Learn about pitfalls and how to avoid them!

Description: Meet the authors of and learn about the contributors to the newly published e-book "Design Your Future with the Competency Framework." Presenters will share their personal reflections, stories and words of wisdom to bring to life the eight professional and personal competencies in the SOA Competency Framework.

Description: Electronic health records (EHRs) are one of the fastest-growing digital health data categories, with over 90% of carriers using or evaluating EHRs for underwriting, according to a recent Munich Re survey. This session brings you up to speed on the current (and future) state of EHRs.

Description: This webcast offers “must know” information and differing perspectives on key IRS procedures that can be utilized by insurance companies to address complex tax issues and situations.

Description: This session introduces you to the next level of gen AI: AI Assistants (also known as Custom GPTs, Gems, or Bots). An AI Assistant is a specialized, tailored version of a Large Language Model (LLM) that allows the user to produce a persistent, pre-programmed tool designed to handle complex, repetitive professional tasks with guaranteed consistency, accuracy, and alignment. We will move beyond casual prompting to explore the mechanical architecture required to build reliable, high-stakes assistants for a variety of applications.

Description: Discover the multitude of risk transfer solutions and payment models available to health claims payers for cell & gene therapies in this Society of Actuaries webinar. Delving deeper into the topic, we will examine the different types of solutions, weigh their pros and cons, and explore the future prospects of this rapidly evolving area of the healthcare landscape. By expanding upon the pricing and risk exposure discussion from session two, this webinar provides valuable insights into the dynamic market for cell & gene therapies and its implications for actuaries.

Description: In this 90-minute webinar, presenters will address 10 career myths (or things people tell you that are not true), and how these relate to actuarial work.

Description: Investigate the importance of collaboration with accounting, underwriting, sales, marketing and other professions as an actuary when you attend this webcast. Cross-functional positions can cause unique challenges to arise, like various experts attempting to balance growth and profitability. Discover an opportunity to learn about relevant ASOPs and dive deeper into contemporary examples that highlight specific professionalism issues that can develop.

Description: Develop a better understanding of specialty drug trends and their increasing healthcare costs for more than the past decade by attending this webcast. With the introduction of price competition, you will see changes in the market for biosimilar products and patent-protected drugs. For example, the drug Humira will be gaining 10 biosimilar competitors in 2023. Alone, Humira can represent over 20% of total pharmacy spend for health plans. Join us and discover how price competition is a turning point for the pharmaceutical industry and will define its direction for the next decade.